10/18/2021 8:38:19 AM
Radius Health Announces Positive Topline Results From ATOM Study
1/5/2021 8:38:54 AM
Endo Ventures Enters Licensing Agreement For Paladin Labs To Commercialize Abaloparatide In Canada
1/5/2021 8:22:41 AM
Radius Health Enters Definitive Agreements With Endo Ventures For Abaloparatide
9/25/2020 5:55:31 AM
Radius Health : Target Enrollment Milestone Reached In Phase 3 EMERALD Study
9/24/2020 8:22:12 AM
Radius Health: Jose Carmona To Be Stepping Down As CFO
8/25/2020 9:12:19 AM
Radius Health Announces Business Update Including Extension Of Patent For TYMLOS
8/10/2020 8:18:36 AM
Radius Health Appoints Sean Murphy To Its Board
8/10/2020 8:18:08 AM
Radius Health Q2 Net Loss $43.9 Mln Or $0.95/Shr Vs Loss $35.5 Mln Or $0.77/Shr Last Year
5/27/2020 5:05:35 AM
Radius Partner Teijin Pharma Submits NDA For Abaloparatide-SC For Treatment Of Osteoporosis In Japan
11/2/2017 9:31:33 PM
Jefferies Is Lowering Radius Health, Inc. (RDUS) FY19 Estimate To -4.03 From -2.94
11/2/2017 9:31:11 PM
Jefferies Is Lowering Radius Health, Inc. (RDUS) FY18 Estimate To -5.19 From -3.85
11/2/2017 9:30:53 PM
Jefferies Is Cutting Radius Health, Inc. (RDUS) FY17 Estimate To -5.72 From -5.19
7/24/2017 7:18:42 AM
Jefferies Is Lowering Radius Health, Inc. (RDUS) 2017 Rev. Estimate To 20.6 M From 155.6 M
7/24/2017 7:18:21 AM
Jefferies Is Lowering Radius Health, Inc. (RDUS) 2017 Estimate To -5.20 From -2.09
7/24/2017 7:18:01 AM
Jefferies Is Lowering Radius Health, Inc. (RDUS) Q4 17 Estimate To -1.20 From -0.17
7/24/2017 7:17:49 AM
Jefferies Is Cutting Radius Health, Inc. (RDUS) Q3 17 Estimate To -1.31 From 0.67